395 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka http://www.zacks.com/stock/news/260741/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka?cid=CS-ZC-FT-260741 May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.
Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls http://www.zacks.com/stock/news/260350/teva-teva-q1-earnings-in-line-sales-lag-as-copaxone-falls?cid=CS-ZC-FT-260350 May 12, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) reported first-quarter 2017 earnings of $1.03 per share (including equity compensation expenses), which was in line with the Zacks Consensus Estimate.
Actavis Generics Acquisition Drives Teva Pharmaceutical Industries Ltd. First-Quarter Sales Higher https://www.fool.com/investing/2017/05/11/actavis-generics-acquisition-drives-teva-pharmaceu.aspx?source=iedfolrf0000001 May 11, 2017 - The specialty and generic drugmaker gets another boost from its 2016 purchase of Actavis Generics from Allergan.
Impax (IPXL) Q1 Earnings Miss, Stock Up on Cost Savings Plan http://www.zacks.com/stock/news/260286/impax-ipxl-q1-earnings-miss-stock-up-on-cost-savings-plan?cid=CS-ZC-FT-260286 May 11, 2017 - Impax Laboratories Inc. (IPXL) posted first-quarter 2017 adjusted earnings of 11 cents per share, missing the Zacks Consensus Estimate of 12 cents. Earnings were down 74.4% from 43 cents in the year-ago period
Allergan Plc (AGN) Q1 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4071181-allergan-plc-agn-q1-2017-results-earnings-call-transcript?source=feed_sector_healthcare May 09, 2017 - Allergan Plc (NYSE:AGN)Q1 2017 Earnings CallMay 09, 2017 8:30 am ETExecutivesDaphne Karydas - Allergan PlcBrenton L. Saunders - Allergan PlcWilliam J. Meury - Allergan PlcC. David Nicholson - Allergan
Early movers: VRX, AGN, W, ODP, PRTY, VZ, WFC, UAL, P & more http://www.cnbc.com/2017/05/09/early-movers-vrx-agn-w-odp-prty-vz-wfc-ual-p-more.html May 09, 2017 - Names on the move ahead of the open.
Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View http://www.zacks.com/stock/news/259943/allergan-agn-beats-q1-earnings-estimates-ups-2017-view?cid=CS-ZC-FT-259943 May 09, 2017 - Allergan plc's (AGN) first-quarter 2017 earnings came in at $3.35 per share, beating the Zacks Consensus Estimate of $3.32 by 0.9%.
Ironwood (IRWD) Q1 Loss Wider than Expected, Sales Miss http://www.zacks.com/stock/news/259920/ironwood-irwd-q1-loss-wider-than-expected-sales-miss?cid=CS-ZC-FT-259920 May 09, 2017 - Ironwood Pharmaceuticals, Inc. (IRWD) reported first-quarter 2017 adjusted loss of 33 cents per share, significantly wider than both the Zacks Consensus Estimate of a loss of 19 cents and the year-ago loss of 8 cents.
Allergan (AGN) Beats Q1 Earnings & Sales; Ups 2017 View http://www.zacks.com/stock/news/259833/allergan-agn-beats-q1-earnings-sales-ups-2017-view?cid=CS-ZC-FT-259833 May 09, 2017 - Allergan???s first-quarter earnings of $3.35 per share were above our consensus estimate of $3.32 per share.
The Top Earnings Charts to Start the Week http://www.zacks.com/stock/news/259797/the-top-earnings-charts-to-start-the-week?cid=CS-ZC-FT-259797 May 08, 2017 - With so many companies reporting earnings, Tracey wades through all the noise to bring you the best charts.
<<<Page 34>